Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140049
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2005-08-29
Brief Title:
A 12week Randomized Evaluator-Masked Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W Glaucoma
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A6641038
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None